Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

257 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial.
Lawitz E, Lalezari JP, Hassanein T, Kowdley KV, Poordad FF, Sheikh AM, Afdhal NH, Bernstein DE, Dejesus E, Freilich B, Nelson DR, Dieterich DT, Jacobson IM, Jensen D, Abrams GA, Darling JM, Rodriguez-Torres M, Reddy KR, Sulkowski MS, Bzowej NH, Hyland RH, Mo H, Lin M, Mader M, Hindes R, Albanis E, Symonds WT, Berrey MM, Muir A. Lawitz E, et al. Among authors: dieterich dt. Lancet Infect Dis. 2013 May;13(5):401-8. doi: 10.1016/S1473-3099(13)70033-1. Epub 2013 Mar 15. Lancet Infect Dis. 2013. PMID: 23499158 Clinical Trial.
Daily versus thrice-weekly interferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected persons: a multicenter randomized controlled trial.
Sulkowski MS, Felizarta F, Smith C, Slim J, Berggren R, Goodman R, Ball L, Khalili M, Dieterich DT; Hepatitis Resource Network Clinical Trials Group. Sulkowski MS, et al. Among authors: dieterich dt. J Acquir Immune Defic Syndr. 2004 Apr 15;35(5):464-72. doi: 10.1097/00126334-200404150-00004. J Acquir Immune Defic Syndr. 2004. PMID: 15021311 Clinical Trial.
Care of patients with hepatitis C and HIV co-infection.
Soriano V, Puoti M, Sulkowski M, Mauss S, Cacoub P, Cargnel A, Dieterich D, Hatzakis A, Rockstroh J. Soriano V, et al. AIDS. 2004 Jan 2;18(1):1-12. doi: 10.1097/00002030-200401020-00001. AIDS. 2004. PMID: 15090824 Review. No abstract available.
Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients.
Torriani FJ, Rodriguez-Torres M, Rockstroh JK, Lissen E, Gonzalez-García J, Lazzarin A, Carosi G, Sasadeusz J, Katlama C, Montaner J, Sette H Jr, Passe S, De Pamphilis J, Duff F, Schrenk UM, Dieterich DT; APRICOT Study Group. Torriani FJ, et al. Among authors: dieterich dt. N Engl J Med. 2004 Jul 29;351(5):438-50. doi: 10.1056/NEJMoa040842. N Engl J Med. 2004. PMID: 15282351 Free article. Clinical Trial.
Intrahepatic CD4+ cell depletion in hepatitis C virus/HIV-coinfected patients.
Canchis PW, Yee HT, Fiel MI, Dieterich DT, Liu RC, Chiriboga L, Jacobson IM, Edlin BR, Talal AH. Canchis PW, et al. Among authors: dieterich dt. J Acquir Immune Defic Syndr. 2004 Sep 1;37(1):1125-31. doi: 10.1097/01.qai.0000131937.52106.92. J Acquir Immune Defic Syndr. 2004. PMID: 15319671
Interferon alfa-2b [correction of alpha-2b]and ribavirin for patients with chronic hepatitis C and normal ALT.
Jacobson IM, Ahmed F, Russo MW, Lebovics E, Dieterich DT, Esposito SP, Bach N, Klion F, Tobias H, Antignano L, Brown RS Jr, Gabbaizadeh D, Geders J, Levendoglu H. Jacobson IM, et al. Among authors: dieterich dt. Am J Gastroenterol. 2004 Sep;99(9):1700-5. doi: 10.1111/j.1572-0241.2004.30049.x. Am J Gastroenterol. 2004. PMID: 15330905 Clinical Trial.
257 results